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Sam Shuster was fond of saying that there are an in finite number of biologies, but only on e matte rs : one can study a ll m anner of pathways in different experim en ta l m odels but ultimately the on ly re levant pathway is the one that causes the disease in the clinic rath er than the 
laboratory. As th e paper by Vrano and colleagues in this issue of the 
journal shows, if you are interested in understanding disease, even 
if that inte res t is in the precise m o lecular processes operatin g in 
disease, at some stage you have to visit the cl inic. 
Cancer is a multi-stage process in wh.ich the accumulatio n of 
genetic abnormaliti es all ows clonal expansion of th e cells harboring 
the changes. Implicit in curren t mode ls is the idea that it is possible 
to map o u t a ca usal re lationship be tween genetic abnorm ali ties and 
clinical behavior [1]. But however eas il y the phrase multi-stage 
carc inogen esis roll s off the tongue, a moment's reRection about the 
c linica l features of non-melano m a skin can cer shows how fa r away 
we are from being ab le to apply m odels developed in other systems 
to human skin ca ncer. How, fo r instance, can we m arry multistage 
carcinogenesis and the developmen t of the most common human 
neoplasm , the basa l ce ll carcin oma (BCC)? T he paper by V rano and 
coll eagues in this issue (p . 928) indirectly addresses this issu e: is 
there a precursor les ion for basa l cell ca rcin om a, and if so how ca n 
it be identified? What are the genetic chan ges that separate norma l 
sun-exposed epide rmis from skin cancer? 
VraJl0 and colleagues presen t one striking and potentiall y fin'-
reaching observation. By ca rrying o ut immunohistocytochemistry 
for p53 on section s of skin close to BCCs, they have iden tified 
clusters of immun ostaining cells adjacent to but separate from the 
BCC. T hey report that these cl usters of p53 immun ostaining cell s, 
which a rc clinica lly and histologically unremarkabl e, harbor p53 
mutations, raising the possibility that these les io ns arc precursors of 
BCC. Are there oth er explanations fo r the ir findin gs? To think 
about this and apprecia te the work one needs to delve a little deeper 
into p53 and cutaneous physio logy. 
Mutatio ns of the p53 gen e ,lre the commo nest genetic abnormal-
ity yet fo und in human cancer, includin g human skin cancer , be ing 
found in BCC, sq uamous cell carcinom as, and pre-invas ive les ions 
such as Bowen ' s disease and actinic keratoses [2-4] . Of particula r 
inte res t is the o bserva tio n by Bras h and co- workers that the pattem 
of base changes fo und in mutant p53 from skin tum ors is what one 
wou ld expect fo ll owin g ultrav io let radiatio n-induced DNA dam-
age [2] . T he frequency of m utation of p53 in hum an neoplasia is 
th o ught to reRect the important physio logic ro le the w ild-type 
protein plays in norma l ce llula r hom eostasis. Afte r DNA damage is 
incurred , w ild-type p53 acts as a cellular brake, allowing DNA 
repair to occur before the cell undergoes division; thus, harmfu l 
mutations are n o t passed on to d aughte r ce ll s. H owever, if the 
burden of damage is beyond the immedi ate repair capabilities of the 
cell , then p53 plays another important ro le, fac ili tating apo ptosis 
[5 ,6]. Again, the net resul t is to minimize the efFect of harmful 
mutati ons to the cell. The relevance of this to cut'lI1 eous bio logy 
and neoplasia is demonstrated by the findin g th at irradia tion w ith 
even sub-erythema l doses of ultra vio let B induces wild-type p53 
protein in skin [7], and knock-out experim en ts suggest that mice 
w ithout p53 are impaired in their ab ili ty to form apoptotic cells in 
skin (sunburn cell s) in response to UV irradiation [5). To under-
stand U rano 's work it is also necessary to realize that although 
mu ta nt p53 protein is abnormally stable and hence accumulates in 
the cell , e levated p53 in keratinocytes may reRect abnormalities 
other th an mutation, such as recent exposure to ultraviolet rad ia-
tion o r other noxious stimuli [7-9] . Immunostaining is not SY1lOn-
ymous with mutation , hence the importance of direct seq uencing 
[4] . 
So w hat are the lesio ns identified by Vrano? A number of points 
arc worthy of comment. First and most obvious, the mutations in 
the skin adjacent to BCC were not fo und in the BCCs. This finding 
is reassuring in that it shows th at the p53 mutations fou n d in th e 
skin adj acent to the tumor cann ot be the result of con tamin ation 
fi~om the tumor. It al so demonstrates , however, that the clusters of 
p53 immunostaining cells adj acent to the tumors cannot be the 
precursors of that particu lar BCC- other-.'V ise on e would have 
expected to find the sam e mutation in both lesions. If they are 
precursors, th ey are precursors of other tumors. Second, the finding 
of a mu tation at codon 249 in all three of the putative precursor 
les io ns is perh aps su rprising. M u tations at codon 249 are un com-
m on in non- m elano ma skin can cer, and these resu lts raise the 
qu estion w hether in this parti cular cellul ar context mutations at 
codon 249 migh t be re lated to regression or non-regression rather 
than to progression to the BCC. T hird, w hy are there cl usters of 
ce lls adjacent to BCCs but not in other sun-exposed sites-is there 
som e clem ent of the micro-environment around a BCC th at allows 
clon al expansion of clones con ta ining p53 mutations? 
How can future work e lu cidate the on togeny of tllese clusters of 
cells harbo ring p53 mutatio ns? O ne way would be to look at the 
pattern of oth er genetic abnormali ties in these cell s. R ecent work 
suggests that loss of chromosome 17 (the chromosom e th at harbors 
p53) is uncomm on in BCC in comparison w ith squamous cell 
carcinomas or actinic keratoses [10,11] . If th e mutations reported 
by Vrano arc really hemizygous, then it would be surprising if they 
turn out to be associated with BCCs. Although Vrano e ( al present 
some data on this poin t, further work is required . An alternative 
way wou ld be to examine whethet· these clones show loss of 
heterozygosity at th e locus responsibl e for the nevoid BCC syn-
drom e 11 2] . R ecen t studies have mapped th e gen e responsible for 
thi s syndrom e to chromosome 9q and have shown th at the vast 
m aj o ri ty of sporadic BCC show loss of heterozygosity at this locus . 
Because loss of 9q is likely to be an earl y event in the development 
of BCC, on e might expect that if the clusters of ceUs identified by 
Vrano arc in deed precursors ofBCCs, they will show the pattern of 
chro mosome 9 loss characteristic of BCCs rather than of squamous 
ce ll carcino mas o r actinic keratoses [13] . Future experiments will 
no doubt resolve many of the questions raised by Vrano e( al. but 
perhaps in som e respects the most important aspect of this work is 
the way it demonstrates how sharp ly and on w hat a fine scale one 
h as to fram e one's experimen ts if nature is to reveal her secrets. 
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